NICE backs Humira, Enbrel and Stelara for plaque psoriasis in children
AbbVie’s Humira, Pfizer’s Enbrel, and Janssen’s Stelara are being recommended as options for treating plaque psoriasis in children and young people on the NHS.
Read More
Tag: Enbrel
Sandoz launches MabThera, Enbrel biosimilars in the UK
Novartis group Sandoz has launched two new biosimilars across the UK potentially expanding access to biologic treatments for a range of inflammatory conditions and blood cancers.
Read More
FDA green light for Sandoz’ Enbrel biosimilar
The US Food and Drug Administration has approved Sandoz’ biosimilar of Amgen’s blockbuster Enbrel.
Read More
FDA advisors back Sandoz’ Enbrel biosimilar
Sandoz’ biosimilar of Amgen’s blockbuster Enbrel has taken a big leap towards US approval after winning unanimous support from regulatory advisors.
Read More
FDA staffers back efficacy of Novartis’ Enbrel biosimilar
US Food and Drug Administration staffers have concluded that Sandoz’ biosimilar of Amgen’s blockbuster Enbrel, dubbed GP2015, is “highly similar” to its reference product, pushing the drug closer to approval.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
